Researchers developed a technique to stimulate T cells with CD28 receptors, making them resistant to HIV infection. The method showed significant improvements in the ratio of CD4 cells to other T cells, indicating sustained immune system recovery.
Researchers at Johns Hopkins Medicine found that bladder exstrophy causes more extensive pelvic girdle bone defects than previously known. The study reveals an outward flare of the hip bone and rotation of the entire pelvic girdle, impacting surgeons' understanding of these defects.
Researchers found that proteins produced by melanocytes trigger attacks on immune cells, leading to hair loss. The discovery could pave the way for more effective treatments for alopecia areata.
A recent analysis of 31 studies found that individuals with HSV-2 infection are twice as likely to contract HIV, with up to half of cases attributed to preceding HSV-2 infection. The study highlights the importance of controlling HSV-2 infection in preventing HIV acquisition.
A study published in Family Relations found that research-based strategies for helping older children establish a positive relationship with a new sibling are not getting sufficient emphasis in the popular press. The authors suggest that writers need to be better tuned into research and address issues important to families.
The American Society for Neuroregeneration and Transplantation (ASNTR) has published guidelines to ensure the development of novel cell and gene replacement therapies for brain disorders. The recommendations focus on preliminary study design, clinical trial methodology, and conflict of interest disclosure.
A NASA-funded study found that people's internal clocks have difficulty adapting to non-24 hour days, leading to increased risk of fatigue and sleepiness. The study, conducted at the National Space Biomedical Research Institute, evaluated participants' melatonin levels in response to varying day lengths.
A study suggests that minocycline, a common antibiotic, could be a potential therapy for multiple sclerosis. The drug showed promising results in rats with autoimmune encephalomyelitis, reducing neurologic dysfunction and disease severity.